Report Name: BAXTER INTERNATIONAL INC. Profile – Overview, History, SWOT Analysis, Products/Services, Facts, Financials, Key Executives, Competitors, Tech Intelligence, IT Outsourcing, IT Management, Recent Developments and Strategy Evaluation
BAXTER INTERNATIONAL INC Report – Publisher: Research Cosmos
Price Scheme of the Report:
Single User License – USD 150
Team License – USD 175
Corporate License – USD 250
BAXTER INTERNATIONAL INC – Business Description:
Baxter International Inc. (Baxter or ‘the company’) is a global provider of treatments for complex medical conditions. The company manufactures its products in 20 countries and markets them in over 100 countries in the US, Canada, Europe, Asia Pacific, the Middle East, Latin America and Africa.
Baxter operates through two business segments: Hospital Products and Renal.
The Hospital Products business segment manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products. The business also provides products and services related to pharmacy compounding, drug formulation and packaging technologies. In FY2016, the Hospital Products segment reported revenues of $6,308 million, which accounted for 62.1% of the company’s total revenue.
The Renal business segment provides products and services to treat end-stage renal disease, or irreversible kidney failure, along with other renal therapies. The renal business segment offers a comprehensive portfolio to meet the needs of patients across the treatment continuum, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. In FY2016, the Renal segment reported revenues of $3,855 million, which accounted for 37.9% of the company’s total revenue.
The company has over 50 manufacturing facilities and over 100 distribution facilities in the US, Europe, Asia Pacific, Latin America and Canada. It sells its products through its own direct sales force as well as through independent distributors, drug wholesalers and specialty pharmacy or other alternate site providers.
Geographically, the company classifies its operations into four segments, namely the US, Europe, Asia Pacific, Latin America and Canada. In FY2016, the US segment accounted for 41.9% of the company’s total net sales, followed by Europe with 26.5%; Asia Pacific with 20%; and Latin America and Canada with 11.6%.
Scope of the Report:
About the Company: Historical Details, Current Ownership Structure and basic overview of Balfour Beatty plcin terms of revenue, net income, and operating income.
Financials: Details about Balfour Beatty plclisting status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.
Products/Services: Listing of the company’s entire portfolio along with the description of individual products/services providing a clear picture of their target audience.
Company SWOT Analysis: Outlines Atea ASA.’s strengths, weaknesses, and opportunities and threats facing the company.
Recent Developments: Showcases Atea ASA.’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.
Strategic Evaluation: This section provides an overview of Atea ASA.’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.
Technology Landscape: Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken by the company at present along with outlook.
Key Questions Answered
What domain does Balfour Beatty plcoperate and what are key points about it?
What is the product/service portfolio of Atea ASA.?
How has Balfour Beatty plcperformed financially from 2013?
How does Balfour Beatty plcrank among its peers in terms of revenue and market share?
What are Balfour Beatty plcstrengths and weaknesses and what opportunities and threats do it face?
What are Atea ASA.’s main growth strategies and how successful has the company been at implementing them?
What is the in-house technical capability of Atea ASA.? Where does it procure/outsource it?
Reasons to buy
Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own
Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at a very competitive cost
12 hour delivery time fulfilling your urgent requests as per your requirement
On-demand customization options that can completely cater to your needs by focusing the report on given specifics
For More Information, Get Sample of the report:Request Sample
Got Some Questions? Inquire Here:Inquire Before Buying
Get This Report:Purchase Now
For More Details, Contact Provider Directly:
+1 888 709 8757